Home Mf Research Hdfc Pharma And Healthcare Fund Regular Plan Growth

HDFC Pharma and Healthcare Fund - Regular Plan - Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
Fund info
NAV (as on 2025-07-18)
17.57 -0.42%
AUM (Fund Size)
N/A
Expense Ratio
2.24%
Exit load
1% within 30 days from the date of allotment.
Risk
N/A
AMC
HDFC Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-07-11 ₹1,000.00 ₹1,022.82
2.28 %
Two Week 2025-07-03 ₹1,000.00 ₹1,033.47
3.35 %
One Month 2025-06-18 ₹1,000.00 ₹1,069.12
6.91 %
Three Months 2025-04-21 ₹3,000.00 ₹3,261.39
8.71 %
Six Months 2025-01-20 ₹6,000.00 ₹6,593.66
9.89 %
One Year 2024-07-18 ₹12,000.00 ₹13,403.20
11.69 %
Since Inception 2023-10-04 ₹22,000.00 ₹28,413.34
29.15 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity 84%
Debt 1%
Others 0%

Sectors Holding in HDFC Pharma and Healthcare Fund - Regular Plan - Growth

Pharmaceuticals & Biotechnology
66%
Healthcare Services
16%
Healthcare Equipment & Supplies
1%
Insurance
1%
Other
1%

Companies Holding in HDFC Pharma and Healthcare Fund - Regular Plan - Growth

Sun Pharmaceutical Industries Ltd.
12.25%
Divis Laboratories Ltd.
10.24%
Cipla Ltd.
7.00%
Lupin Ltd.
5.59%
Max Healthcare Institute Limited
4.83%
Glenmark Pharmaceuticals Ltd.
4.12%
Ipca Laboratories Ltd.
3.99%
Krishna Institute Of Medical Sciences Limited
3.95%
Aster DM Healthcare Limited
3.92%
Eris Lifesciences Ltd
3.54%
Torrent Pharmaceuticals Ltd.
3.42%
Aurobindo Pharma Ltd.
3.11%
Wockhardt Ltd.
2.95%
Gland Pharma Ltd.
2.75%
Alkem Laboratories Ltd.
2.63%
Metropolis Healthcare Ltd.
2.42%
Vijaya Diagnostic Centre Limited
2.39%
Acutaas Chemicals Limited
2.20%
Piramal Pharma Limited
2.12%
Cohance Lifesciences Limited
1.95%
Dr. Lal Path Labs Ltd
1.78%
Jubilant Pharmova Limited
1.78%
Fortis Healthcare Limited
1.62%
Pfizer Ltd.
1.62%
Laxmi Dental Limited
1.45%
BAJAJ HEALTHCARE LIMITED - Prefential Issue
1.25%
Sai Life Sciences Limited
1.13%
Medi Assist Healthcare Services Limited
1.08%
Zydus Lifesciences Limited
1.08%
Ajanta Pharma Limited
0.70%
BAJAJ HEALTHCARE LIMITED
0.35%
TREPS - Tri-party Repo
1.08%
Net Current Assets
-0.29%

Risk Ratios

Std. Deviation 14.882
Beta 0.753
Sharpe Ratio 3.264
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
2.24
Expense Ratio Direct
1.01
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Nikhil Mathur
Over 14 years Experience
Dhruv Muchhal
Over 10 years Experience

Exit load

1% within 30 days from the date of allotment.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?